Cathie Wood’s ARK sells DraftKings stock and buys CRISPR Therapeutics
Covered in this story
Analyst targets on Crispr Therapeutics AG
- Morgan Stanley: $48.4 → $60 by Jul 2027 · Equal Weight via Yahoo Finance
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $CRSP yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Crispr Therapeutics AG →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.